Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |